We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sinclair Pha | LSE:SPH | London | Ordinary Share | GB0033856740 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.80 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSPH
RNS Number : 0385C
Sinclair Pharma PLC
16 January 2018
Sinclair Pharma plc
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
London, 16 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that today, Julie Spooner, wife of Chris Spooner, Chief Executive Officer, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.15p per Ordinary Share.
Following these purchases, Chris Spooner's total beneficial interest is 10,440,479 Ordinary Shares, 2.07% of the issued share capital of the Group.
For further information please contact:
Sinclair Pharma Tel: +44 (0) plc 20 7467 6920 Chris Spooner Alan Olby Andy Crane Peel Hunt LLP (NOMAD and Tel: +44 (0) 20 7418 Joint Broker) 8900 James Steel Oliver Jackson RBC Capital Markets (Joint Tel: +44 (0) 20 7653 Broker) 4000 Marcus Jackson Laura White 1. Details of the person discharging managerial responsibilities / person closely associated --- ----------------------------------------------------------------------- a. Name Julie Spooner --- ------------------------------ --------------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------------- a. Position/status Wife of Chris Spooner, Chief Executive Officer --- ------------------------------ --------------------------------------- b. Initial Initial Announcement notification /Amendment --- ------------------------------ --------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------- a. Name Sinclair Pharma plc --- ------------------------------ --------------------------------------- b. LEI 213800BNMD7JVMHW1772 --- ------------------------------ --------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------- a. Description Ordinary Shares of 1 pence each of the in Sinclair Pharma plc Financial instrument, type of instrument GB0033856740 Identification code --- ------------------------------ --------------------------------------- b. Nature of Purchase the transaction --- ------------------------------ --------------------------------------- c. Price(s) Price(s) Volume(s) and volume(s) --------- ---------- 23.15p 200,000 --------- ---------- --- ------------------------------ --------------------------------------- d. Aggregated information N/A * Aggregated volume * Price --- ------------------------------ --------------------------------------- e. Date of 2018-01-16 the transaction --- ------------------------------ --------------------------------------- f. Place of London Stock Exchange, AIM the transaction --- ------------------------------ ---------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZQLFFVFFFBBX
(END) Dow Jones Newswires
January 16, 2018 09:15 ET (14:15 GMT)
1 Year Sinclair Pharma Chart |
1 Month Sinclair Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions